StockData

Integra LifeSciences vs Merit Medical Systems

IART and MMSI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IART and MMSI compare

Merit Medical Systems is the larger company, worth 4.8 times as much as Integra LifeSciences ($5.2B against $1.1B).

On earnings, Merit Medical Systems is cheaper: it trades at 32.5× trailing earnings, against 82.2× for Integra LifeSciences.

Merit Medical Systems grew revenue faster over the last twelve months (9.1% versus 0.84% for Integra LifeSciences).

Merit Medical Systems keeps more of each dollar of sales as profit, with a net margin of 9.9% compared with 0.79% at Integra LifeSciences.

Merit Medical Systems scores higher on the StockData Score (13 against 9 for Integra LifeSciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIARTMMSI
Size and price
Market cap$1.1B$5.2B
Share price$13.98$86.35
Change, 1 year16.1%−1.2%
Change, 5 years−78.4%30.6%
Beta (5Y)1.870.30
Employees3,7007,500
StockData Score
Total score913 (better)
Valuation score34 (better)
Growth score22
Performance score33
Health score14 (better)
Dividend score00
Valuation
P/E82.2×32.5× (better)
P/S0.7× (better)3.2×
P/B1.0× (better)3.0×
EV/EBITDA10.7× (better)15.8×
P/FCF12.7× (better)25.4×
PEG–1.78
FCF yield7.9% (better)3.9%
Fair value$14.79$92.96
Margin of safety5.5%7.1% (better)
Growth
Revenue growth (TTM)0.84%9.1% (better)
Revenue growth, 5Y average3.6%9.5% (better)
Net income growth (TTM)–35.2%
EPS growth (TTM)–36.4%
Profitability
Gross margin52.4% (better)49.4%
Operating margin4.4%13.5% (better)
Net margin0.79%9.9% (better)
FCF margin5.2%12.6% (better)
Return on equity1.2%9.8% (better)
Return on invested capital5.6%8.5% (better)
Financial health
Debt / equity–0.42
Net debt / EBITDA–0.68
Interest coverage0.8×6.7× (better)
Current ratio3.624.52 (better)
Altman Z-score1.284.26 (better)
Piotroski F-score57 (better)
Dividends and buybacks
Buyback yield–−0.43%
Shareholder yield0.00% (better)−0.43%
Ownership
Held by institutions94.4%105%
Held by insiders3.4%2.7%
Insider net buying, 12 months$0 (better)−$2.7M
Short interest, % of float10.5%6.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.